$1.47B
$224 Million
0.02% of portfolio
10,668
Q2 2025
Reduced 61.11%
$53B
$213 Million
0.02% of portfolio
398
Q2 2025
Added 7.28%
$1.16B
$172 Million
0.02% of portfolio
2,512
Q2 2025
Added 70.65%
$239M
$210 Million
0.02% of portfolio
26,703
Q2 2025
Added 772.08%
$5.27B
$198 Million
0.02% of portfolio
1,786
Q2 2025
Added 16.05%
$3.13B
$186 Million
0.02% of portfolio
2,964
Q1 2025
Reduced 84.04%
$5.94B
$224 Million
0.02% of portfolio
9,203
Q2 2025
Added 0.63%
-
$166 Million
0.02% of portfolio
-
Q2 2025
Added 47.99%
$2.13B
$208 Million
0.02% of portfolio
22,215
Q2 2025
Reduced 57.14%
$1.63B
$246 Million
0.02% of portfolio
11,767
Q2 2025
Added 184.36%
-
$203 Million
0.02% of portfolio
-
Q2 2025
Added 1,325.52%
$11.9B
$200 Million
0.02% of portfolio
4,666
Q2 2025
Reduced 2.99%
$4.38B
$159 Million
0.02% of portfolio
2,320
Q2 2025
Reduced 54.76%
$945M
$180 Million
0.02% of portfolio
3,008
Q2 2025
Reduced 58.44%
$5.47B
$194 Million
0.02% of portfolio
1,257
Q2 2025
Added 344.17%
-
$171 Million
0.02% of portfolio
-
Q2 2025
Reduced 91.22%
$1.12B
$224 Million
0.02% of portfolio
9,698
Q2 2025
Added 3,658.91%
$6.11B
$158 Million
0.02% of portfolio
3,302
Q2 2025
Reduced 79.48%
-
$253 Million
0.02% of portfolio
-
Q2 2025
Added 276.04%
$4.74B
$188 Million
0.02% of portfolio
5,476
Q2 2025
Reduced 78.48%
$708M
$156 Million
0.02% of portfolio
8,119
Q2 2025
Added 9.11%
$591M
$179 Million
0.02% of portfolio
20,365
Q2 2025
Reduced 80.13%
$4.68B
$195 Million
0.02% of portfolio
2,950
Q2 2025
Reduced 55.79%
$31.3B
$158 Million
0.02% of portfolio
6,120
Q2 2025
Reduced 0.46%
$668M
$169 Million
0.02% of portfolio
29,217
Q2 2025
Reduced 50.29%
$3.31B
$222 Million
0.02% of portfolio
5,090
Q2 2025
New
$9.65B
$186 Million
0.02% of portfolio
3,806
Q2 2025
New
-
$195 Million
0.02% of portfolio
-
Q2 2025
Added 291.62%
$26.4B
$226 Million
0.02% of portfolio
1,435
Q2 2025
Added 328.36%
$1.15B
$210 Million
0.02% of portfolio
2,144
Q2 2025
Added 154.03%
$991M
$222 Million
0.02% of portfolio
1,588
Q2 2025
Added 122.1%
$1.42B
$254 Million
0.02% of portfolio
1,760
Q2 2025
Added 537.68%
$229M
$160 Million
0.02% of portfolio
8,765
Q2 2025
Reduced 50.92%
$27B
$250 Million
0.02% of portfolio
668
Q2 2025
Added 0.15%
$6.96B
$191 Million
0.02% of portfolio
12,101
Q2 2025
Added 154.97%
$1.76B
$173 Million
0.02% of portfolio
4,292
Q2 2025
Added 61,214.29%
-
$186 Million
0.02% of portfolio
-
Q2 2025
New
$71.8B
$186 Million
0.02% of portfolio
2,399
Q2 2025
Reduced 65.34%
$15.8B
$173 Million
0.02% of portfolio
2,691
Q2 2025
Reduced 92.84%
$9.36B
$247 Million
0.02% of portfolio
7,981
Q2 2025
Reduced 2.5%
$16.8B
$179 Million
0.02% of portfolio
2,367
Q2 2025
Reduced 44.48%
$3.94B
$203 Million
0.02% of portfolio
12,183
Q2 2025
Added 1,227.12%
$425M
$253 Million
0.02% of portfolio
23,150
Q2 2025
Reduced 55.61%
$1.62B
$160 Million
0.02% of portfolio
9,839
Q2 2025
Reduced 22.1%
$1.65T
$176 Million
0.02% of portfolio
238
Q2 2025
Reduced 92.91%
$3.86T
$170 Million
0.02% of portfolio
342
Q2 2025
Added 5.88%
$7.3B
$158 Million
0.02% of portfolio
1,100
Q2 2025
Reduced 22.21%
$363M
$156 Million
0.02% of portfolio
9,027
Q2 2025
Added 23,655.26%
$766M
$200 Million
0.02% of portfolio
32,744
Q2 2025
Reduced 36.91%
Mineralys Therapeutics Inc
-
$201 Million
0.02% of portfolio
-
Q2 2025
Reduced 6.81%